Endocrinology

The FDA has approved Baqsimi nasal powder, the first glucagon therapy for the emergency treatment of severe hypoglycemia that can be administered without an injection.

The FDA has approved an oral gonadotropin-releasing hormone antagonist for the treatment of moderate to severe endometriosis pain.

The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.

The US Food and Drug Administration has approved a new treatment for osteoporosis for postmenopausal women at a high risk for fracture.

The FDA approved Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease who are on hemodialysis.

The FDA has approved several new drugs that medical professionals should be aware of.

NPS Pharmaceuticals Inc's hormone replacement therapy Natpara appears effective, though data from one clinical trial site was excluded due to manufacturing violations, according to a preliminary report...

Vanda Pharmaceuticals Inc said on Friday that U.S. health regulators have approved its experimental drug to regulate the internal body clocks of blind patients and help normalize sleep patterns.